Agilent Technologies, Inc. (NYSE:A) Shares Sold by Oakworth Capital Inc.

Oakworth Capital Inc. decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 9.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,089 shares of the medical research company’s stock after selling 118 shares during the period. Oakworth Capital Inc.’s holdings in Agilent Technologies were worth $146,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. CKW Financial Group boosted its holdings in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares in the last quarter. Livelsberger Financial Advisory purchased a new position in Agilent Technologies in the third quarter valued at about $28,000. Ashton Thomas Securities LLC acquired a new stake in shares of Agilent Technologies during the 3rd quarter valued at approximately $31,000. Fortitude Family Office LLC boosted its stake in shares of Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after acquiring an additional 95 shares in the last quarter. Finally, Hanson & Doremus Investment Management grew its holdings in shares of Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares during the period.

Agilent Technologies Stock Down 0.2 %

A stock opened at $147.66 on Friday. Agilent Technologies, Inc. has a one year low of $124.16 and a one year high of $155.35. The stock has a market capitalization of $42.17 billion, a P/E ratio of 33.41, a PEG ratio of 4.10 and a beta of 1.07. The company has a 50 day moving average price of $141.25 and a two-hundred day moving average price of $139.13. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm posted $1.38 earnings per share. The business’s quarterly revenue was up .8% compared to the same quarter last year. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were given a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a dividend yield of 0.67%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.40%.

Analyst Ratings Changes

Several equities analysts recently issued reports on A shares. Citigroup lifted their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Barclays lowered their price objective on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research note on Wednesday, November 27th. Bank of America dropped their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Finally, Sanford C. Bernstein dropped their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Hold” and an average target price of $143.62.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.